BRCA1 and breast cancer: It was noteworthy that the single significant discovery was made in a subgroup of women with BRCA1 pathogenic variants and ER-negative breast cancer, and this was attenuated in the wider analysis of all BRCA1 carriers, because inclusion of the ER-positive breast cancer cases, where the association did not exist, diluted the effect in the combined analysis.